GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Metacare Co Ltd (XKRX:118000) » Definitions » Cyclically Adjusted PS Ratio

Metacare Co (XKRX:118000) Cyclically Adjusted PS Ratio : 0.41 (As of Jun. 01, 2025)


View and export this data going back to 2009. Start your Free Trial

What is Metacare Co Cyclically Adjusted PS Ratio?

As of today (2025-06-01), Metacare Co's current share price is ₩343.00. Metacare Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 was ₩839.14. Metacare Co's Cyclically Adjusted PS Ratio for today is 0.41.

The historical rank and industry rank for Metacare Co's Cyclically Adjusted PS Ratio or its related term are showing as below:

XKRX:118000' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.29   Med: 0.58   Max: 2.07
Current: 0.41

During the past years, Metacare Co's highest Cyclically Adjusted PS Ratio was 2.07. The lowest was 0.29. And the median was 0.58.

XKRX:118000's Cyclically Adjusted PS Ratio is ranked better than
87.67% of 738 companies
in the Drug Manufacturers industry
Industry Median: 2.12 vs XKRX:118000: 0.41

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Metacare Co's adjusted revenue per share data for the three months ended in Mar. 2025 was ₩36.377. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is ₩839.14 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Metacare Co Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Metacare Co's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Metacare Co Cyclically Adjusted PS Ratio Chart

Metacare Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.14 0.85 0.32 0.43 0.33

Metacare Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.59 0.52 0.40 0.33 0.36

Competitive Comparison of Metacare Co's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - General subindustry, Metacare Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Metacare Co's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Metacare Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Metacare Co's Cyclically Adjusted PS Ratio falls into.


;
;

Metacare Co Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Metacare Co's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=343.00/839.14
=0.41

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Metacare Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Metacare Co's adjusted Revenue per Share data for the three months ended in Mar. 2025 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=36.377/122.5900*122.5900
=36.377

Current CPI (Mar. 2025) = 122.5900.

Metacare Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201506 176.247 100.051 215.952
201509 172.400 100.111 211.111
201512 286.160 100.220 350.032
201603 290.782 100.561 354.481
201606 163.790 100.791 199.215
201609 91.766 101.461 110.876
201612 67.349 101.561 81.294
201703 112.138 102.851 133.660
201706 316.682 102.611 378.341
201709 463.198 103.491 548.683
201712 637.329 102.991 758.613
201803 378.284 104.101 445.471
201806 285.697 104.130 336.344
201809 298.520 105.651 346.383
201812 347.635 104.351 408.398
201903 227.337 104.491 266.715
201906 326.484 104.881 381.611
201909 887.885 105.200 1,034.653
201912 576.464 105.121 672.259
202003 98.579 105.354 114.706
202006 204.673 105.112 238.706
202009 124.298 106.198 143.484
202012 -189.935 105.765 -220.149
202103 28.702 107.357 32.774
202106 94.013 107.579 107.131
202109 101.057 108.759 113.908
202112 29.770 109.676 33.275
202203 64.315 111.848 70.492
202206 58.794 114.072 63.184
202209 55.561 114.715 59.375
202212 48.074 115.179 51.167
202303 50.557 116.507 53.196
202306 47.434 117.182 49.623
202309 40.544 118.964 41.780
202312 30.691 118.837 31.660
202403 34.225 120.123 34.928
202406 33.960 120.007 34.691
202409 30.416 120.861 30.851
202412 35.678 121.135 36.106
202503 36.377 122.590 36.377

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Metacare Co  (XKRX:118000) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Metacare Co Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Metacare Co's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Metacare Co Business Description

Traded in Other Exchanges
N/A
Address
202, 156, Byeongjeomjungang-ro, Jinan-dong, Dream Buildiing, Gyeonggi-do, Hwaseong-si, KOR
Metacare Co Ltd formerly Smedi Co Ltd has established a hospital in Jeju and exports various types of medical equipments. The company also built its own hospital in China and India and plans to expand its business in Spain and Dubai. The Company and its subsidiaries are divided into pharmaceutical business, medical business, wireless device business, investment and others according to business characteristics by business sector.

Metacare Co Headlines

No Headlines